Related Experiment Videos
Nodular scleroderma: focally increased tenascin expression differing from that in the surrounding scleroderma skin
H Mizutani1, H Taniguchi, T Sakakura
1Department of Dermatology, Mie University Faculty of Medicine, Tsu, Japan.
The Journal of Dermatology
|April 1, 1995
Summary
Nodular scleroderma, a rare disease variant, shows high tenascin expression in rapidly resolving nodules, suggesting a pathogenesis similar to hypertrophic scars rather than systemic sclerosis.
Area of Science:
- Dermatology
- Extracellular Matrix Biology
- Connective Tissue Diseases
Background:
- Nodular scleroderma is a rare scleroderma variant with uncertain pathogenesis.
- Tenascin, an extracellular matrix protein, is a marker for tissue remodeling.
- Investigating tenascin expression aids in understanding nodular scleroderma's development.
Observation:
- A case of nodular scleroderma was studied, examining tenascin expression in lesions.
- Progressive systemic sclerosis (PSS) shows intermediate, long-lasting tenascin expression.
- Morphea and hypertrophic scars exhibit strong, short-lived tenascin expression.
Findings:
- The current patient's nodular lesions displayed high tenascin levels and rapid resolution.
- This pattern of tenascin expression and clinical course resembles hypertrophic scars.
- Findings suggest nodular scleroderma may have a pathogenesis distinct from PSS.
Implications:
- Nodular scleroderma might involve additional pathogenetic factors, such as itching.
- Understanding tenascin's role can differentiate nodular scleroderma from PSS.
- This research offers insights into the complex mechanisms of scleroderma variants.